About Us
Aitua is led by an experienced management team of successful serial entrepreneurs. Between them they have:
- Built and exited over 15 life science companies during the last 20 years
- Generated significant returns through trade sales and IPOs
- Achieved mergers and acquisitions
- Invested as both angels and venture capitalists
Aitua brings investment expertise to the process of identifying IP with commercial value. It selects high quality opportunities which are supported from company creation to a clear exit. This is a fundamentally different approach to traditional spin-out formation, and provides the basis for value creation in Aitua.
The company is situated in the bio incubator on Babraham Research Campus giving easy access to world class research emerging from Cambridge University, Addenbrookes Hospital and the Research Council Institutes at the Sanger Centre and Babraham. This enables Aitua to have a close relationship with BBSRC and access to specialised networks and facilities.
Aitua has an exclusive 10-year pipeline agreement with the Babraham Institute giving it the right to form companies around novel intellectual property created at the Institute.
Aitua has freedom to invest in world class deals wherever they originate.
It has alliances with IP development Partners
including academic institutions and R&D rich corporations. These provide
the source of emerging IP for both portfolio companies and new investments.